SAFE SUPPLY STREAMING CO - SSPLF STOCK NEWS

Safe Supply Streaming Co announces a strategic partnership between its portfolio company, Safety Strips Tech Corp, and Greenlane Holdings (NASDAQ: GNLN) for the distribution of Toxi Shield iodine tablets. The tablets, manufactured in a GMP-certified facility in the USA, are designed to protect the thyroid gland during radiation emergencies.

The agreement, dated November 7, 2024, grants Greenlane exclusive distribution rights globally. This collaboration aligns with recent directives from Swedish and Norwegian governments regarding potassium iodide tablet supplies and addresses growing concerns about nuclear safety and emergency preparedness.

Safe Supply Streaming Co (CSE: SPLY) has appointed Jordan Greenberg as its new Chief Financial Officer, effective December 3, 2024. Greenberg, a seasoned financial executive with extensive public company experience, replaces outgoing CFO Geoff Kritzinger. The leadership change comes as the company strengthens its position in the medical technology sector, particularly focusing on harm reduction tools following the acquisition of Drug Lab 118. The company's portfolio includes Safety Strips Tech Corp. and drink spike tests, marking its strategic shift into medical technology and public health solutions.

Safe Supply Streaming Co (SSPLF) has completed the acquisition of Drug Lab 118 in an all-share transaction, issuing 10 million common shares at $0.05 per share. The acquisition includes Drug Lab US's proprietary harm reduction test strips, strengthening Safe Supply's position in North American markets. The shares are subject to resale restrictions over 12 months, with one-third becoming tradeable at 4, 8, and 12-month intervals. Additionally, 1 million shares were issued as a finder's fee. Seymour Paul Ferreira joins Safe Supply's board, bringing health-tech expertise. The global drug testing and harm reduction market is projected to reach $11.83 billion by 2028 with a 5.0% CAGR.

Safe Supply Streaming Co. announces updates on its portfolio company Safety Strips Tech Corp., which has secured an exclusive U.S. distribution agreement with Greenlane Holdings Inc. for its proprietary test strips. The products detect substances like fentanyl and xylazine, addressing the opioid crisis through affordable testing solutions. The ISO 13485 validated Fentanyl Test Strip can detect trace amounts of synthetic opioids within five minutes. The company plans to expand distribution through universities and government programs, leveraging partnerships to maximize market reach of these high-margin products.

Safe Supply Streaming (SSPLF) has signed a definitive agreement to acquire 100% of Drug Lab 118 through a share purchase valued at $0.05 per share, totaling 10,000,000 common shares. The acquisition enhances Safe Supply's portfolio of proprietary products in the medical testing and harm reduction sector. The deal includes contractual resale restrictions over 12 months and the issuance of 1,000,000 finder fee shares. Drug Lab US brings expertise in harm reduction test strips development, strengthening Safe Supply's position in the North American market. The integration aims to address growing regulatory requirements and consumer safety needs in the rapidly expanding harm reduction market.

Safe Supply Streaming Co. (SSPLF) has announced two strategic developments with Safety Strips Tech Corp: a non-binding LOI to acquire the remaining interest for 100% ownership through an all-share transaction, and the issuance of a $50,000 promissory note at 5% interest for working capital. Safety Strips is a medical testing company specializing in harm reduction products, including test strips for detecting illicit substances. The acquisition complements Safe Supply's recent Drug Lab acquisition and provides near-term revenue opportunities through existing distribution agreements. Safe Supply currently holds 3,500,000 shares of Safety Strips, with the final consideration to be determined after due diligence.

Safe Supply Streaming Co (CSE: SPLY) provides a corporate update on its recent progress and strategic initiatives. The company's Safety Strips product line and proposed acquisition of DrugLabs118 have garnered significant investor interest, with over 12 million shares traded in September. Safe Supply Streaming addresses two critical public health issues: drink spiking and fentanyl-related overdoses.

The company's core innovation, Safety Strips, offers an easy-to-use detection method for harmful substances in beverages. The strategic acquisition of DrugLabs118 strengthens its position in the drug testing market. Safe Supply Streaming is actively commercializing its products through a partnership with Greenlane Holdings Inc. (NASDAQ: GNLN) and exploring potential collaborations with med-tech companies.

The company reports a substantial increase in trading volume, with approximately 24.6 million shares traded over the past two months, reflecting growing investor confidence. Safe Supply Streaming positions itself as a high-growth opportunity for institutional investors in the med-tech space.

Safe Supply Streaming Co (CSE: SPLY) reports increased investor interest following an interview with Safety Strips CEO Geoff Benic, highlighting their role in combating the opioid crisis. The opioid overdose treatment market is expected to reach $1.54 billion in 2024. Greenlane Holdings, Inc. (NASDAQ: GNLN) has partnered with Safety Strips to distribute fentanyl, xylazine, and drink-spike detection test strips across North America.

Safety Strips' products are set to launch on September 25, 2024, with shipments beginning October 1, 2024. These test strips offer a quick solution for preventing accidental overdoses and drink-spiking incidents. Safe Supply Streaming is positioned to capitalize on the growing market for safety products, with their ISO 13485 validated products. The company is exploring partnerships to expand Safety Strips' scope and develop additional tests addressing public safety needs.

Safe Supply Streaming Co (CSE: SPLY) announces the launch of Safety Strips, a portfolio company introducing high-performing drug detection strips to combat fentanyl, xylazine, and drink spiking. The product will be distributed through Greenlane Holdings, Inc. (NASDAQ: GNLN) starting October 1, 2024. This initiative addresses the opioid epidemic and aligns with new California legislation (AB 1013) mandating bars and clubs to offer drug testing kits.

The launch is expected to create value for Safe Supply shareholders by enhancing market reach through Greenlane's distribution channels and meeting critical public safety needs. The U.S. opioid crisis has seen drug overdose fatalities increase nearly sixfold since 2000, with 71,000 deaths linked to fentanyl in 2021. Drink spiking also poses a significant threat, with over 320,000 reported cases of rape and sexual assault in 2016.